DATABASE PUBMED

( MICROBIOTA STUNTED/STUNTING )

1. Influence of gut microbiota on neuropsychiatric disorders.

2. Microbiota Transfer Therapy alters gut ecosystem and improves
gastrointestinal and autism symptoms: an open-label study.
3. Gut microbiota and gastric disease.
4. Duodenal Microbiota in Stunted Undernourished Children with Enteropathy.
5. Factors affecting early-life intestinal microbiota development.
6. Relationship between intestinal microbiota and ulcerative colitis: Mechanisms
and clinical application of probiotics and fecal microbiota transplantation.
7. The Relationship Between the Serotonin Metabolism, Gut-Microbiota and the
Gut-Brain Axis.
8. Effects of microbiota-directed foods in gnotobiotic animals and
undernourished children.
9. Tryptophan Metabolism: A Link Between the Gut Microbiota and Brain.
10. Stunted microbiota and opportunistic pathogen colonization in caesarean-
section birth.
11. The role of the gut microbiota in development, function and disorders of the
central nervous system and the enteric nervous system.
12. The gut microbiome and the brain.
13. The Central Nervous System and the Gut Microbiome.
14. Diet in Irritable Bowel Syndrome (IBS): Interaction with Gut Microbiota and
Gut Hormones.
15. Exercise influence on the microbiome-gut-brain axis.
16. Dynamics and Stabilization of the Human Gut Microbiome during the First
Year of Life.
17. Microbiota and neurodevelopmental windows: implications for
brain disorders.
18. Nutrients and Microbiota in Lung Diseases of Prematurity: The Placenta-Gut-
Lung Triangle.
19. PPARs and Microbiota in Skeletal Muscle Health and Wasting.
20. Environmental Enteric Dysfunction and Growth Failure/Stunting in Global
Child Health.
21. Intestinal IgA as a modulator of the gut microbiota.
22. Gut microbiota remodeling reverses aging-associated inflammation and
dysregulation of systemic bile acid homeostasis in mice sex-specifically.
23. The gut microbiota: An emerging risk factor for cardiovascular and
cerebrovascular disease.
24. Control of lupus nephritis by changes of gut microbiota.
25. Development of the Pediatric Gut Microbiome: Impact on Health and Disease.
26. Gut bacteria that prevent growth impairments transmitted
by microbiota from malnourished children.
27. Persistent gut microbiota immaturity in malnourished Bangladeshi children.
28. Small Intestinal Bacterial Overgrowth in Children: A State-Of-The-Art Review.
29. Akkermansia muciniphila and its role in regulating host functions.
30. AGA Clinical Practice Guidelines on the Role of Probiotics in the Management
of Gastrointestinal Disorders.
31. Modulation of Gut Microbiota Composition by Serotonin Signaling Influences
Intestinal Immune Response and Susceptibility to Colitis.
32. Our Gut Microbiome: The Evolving Inner Self.
33. Interactions between gut microbiota and skeletal muscle.
34. High-Glucose or -Fructose Diet Cause Changes of the Gut Microbiota and
Metabolic Disorders in Mice without Body Weight Change.
35. Intervention strategies for cesarean section-induced alterations in
the microbiota-gut-brain axis.
36. Probiotic supplements might not be universally-effective and safe: A review.
37. Immunotoxicity and intestinal effects of nano- and microplastics: a review of
the literature.
38. Human Milk Oligosaccharides: 2'-Fucosyllactose (2'-FL) and Lacto-N-
Neotetraose (LNnT) in Infant Formula.
39. Ablation of gut microbiota alleviates obesity-induced hepatic steatosis and
glucose intolerance by modulating bile acid metabolism in hamsters.
40. Pathogenesis and post-infectious complications in giardiasis.
41. Early nutrition and gut microbiome: interrelationship between bacterial
metabolism, immune system, brain structure, and neurodevelopment.
42. The Perturbance of Microbiome and Gut-Brain Axis in Autism
Spectrum Disorders.
43. Growing up in a Bubble: Using Germ-Free Animals to Assess the Influence of
the Gut Microbiota on Brain and Behavior.
44. Vitamin D signaling maintains intestinal innate immunity and gut microbiota:
potential intervention for metabolic syndrome and NAFLD.
45. Connection between gut microbiome and brain development in preterm
infants.
46. The effect of fiber and prebiotics on children's gastrointestinal disorders and
microbiome.
47. The canine gastrointestinal microbiota: early studies and research frontiers.
48. Gut microbiota: puppeteer of the host juvenile growth.
49. Turning the "Phage" on Malnutrition and Stunting.
50. Gut commensal Parabacteroides goldsteinii plays a predominant role in the
anti-obesity effects of polysaccharides isolated from Hirsutella sinensis.
51. Does the Gut Microbiota Modulate Host Physiology through Polymicrobial
Biofilms?
52. Molecular mechanisms of the rapid-acting and long-lasting antidepressant
actions of (R)-ketamine.
53. Lactic acid bacteria alleviate polycystic ovarian syndrome by regulating sex
hormone related gut microbiota.
54. Does the gut microbiota contribute to the oligodendrocyte progenitor niche?
55. Annual Research Review: Critical windows - the microbiota-gut-brain axis in
neurocognitive development.
56. Environmental enteric dysfunction pathways and child stunting: A systematic
review.
57. Eosinophils in the gastrointestinal tract and their role in the pathogenesis of
major colorectal disorders.
58. [Gut microbiota in health and disease].
59. Non-Melanoma Skin Cancer: news from microbiota research.
60. Food matters: how the microbiome and gut-brain interaction might impact
the development and course of anorexia nervosa.
61. AGA Technical Review on the Role of Probiotics in the Management of
Gastrointestinal Disorders.
62. Signs and symptoms associated with digestive tract development.
63. Microbiota-Sourced Purines Support Wound Healing and Mucous Barrier
Function.
64. Childhood undernutrition, the gut microbiota, and microbiota-directed
therapeutics.
65. Assessing the Intestinal Microbiota in the SHINE Trial.
66. Butyrate producing colonic Clostridiales metabolise human milk
oligosaccharides and cross feed on mucin via conserved pathways.
67. Prebiotic inulin-type fructans and galacto-oligosaccharides: definition,
specificity, function, and application in gastrointestinal disorders.
68. Impact of nasopharyngeal microbiota on the development of respiratory tract
diseases.
69. Intestinal microbiota, diet and health.
70. Interactions of probiotics and prebiotics with the gut microbiota.
71. Microbiota on biotics: probiotics, prebiotics, and synbiotics to
optimize growth and metabolism.
72. Programming Bugs: Microbiota and the Developmental Origins of Brain
Health and Disease.
73. Regulation of barrier immunity and homeostasis by integrin-mediated
transforming growth factor beta activation.
74. Oral Administration of miR-30d from Feces of MS Patients Suppresses MS-like
Symptoms in Mice by Expanding Akkermansia muciniphila.
75. Changes in Faecal Microbiota Profiles Associated With Performance and
Birthweight of Piglets.
76. Standardized Preparation for Fecal Microbiota Transplantation in Pigs.
77. Intestinal microbial dysbiosis aggravates the progression of
Alzheimer's disease in Drosophila.
78. Potential vaginal probiotics: safety, tolerability and preliminary effectiveness.
79. The Microbiota and Malnutrition: Impact of Nutritional Status During Early
Life.
80. Upper gastrointestinal microbiota and digestive diseases.
81. Microbiota - a key to healing the gastrointestinal tract?
82. Reframing the Teenage Wasteland: Adolescent Microbiota-Gut-Brain Axis.
83. Comparison of Healthy and Dandruff Scalp Microbiome Reveals the Role of
Commensals in Scalp Health.
84. What's bugging your teen?-The microbiota and adolescent mental health.
85. Factors affecting the composition of the gut microbiota, and its modulation.
86. [Intestinal microbiota, nutrients and probiotics viewed from the "gut-lung"
axis].
87. An increase in the Akkermansia spp. population induced by metformin
treatment improves glucose homeostasis in diet-induced obese mice.
88. Gut-Amygdala Interactions in Autism Spectrum Disorders: Developmental
Roles via regulating Mitochondria, Exosomes, Immunity and microRNAs.
89. [Current view on gut microbiota].
90. Differential modulation by Akkermansia muciniphila and Faecalibacterium
prausnitzii of host peripheral lipid metabolism and histone acetylation in
mouse gut organoids.
91. Carbohydrates and the human gut microbiota.
92. Altered diversity and composition of gut microbiota in Wilson's disease.
93. Dynamic changes in intestinal microbiota in young forest musk deer during
weaning.
94. A Budding Relationship: Bacterial Extracellular Vesicles in the Microbiota-Gut-
Brain Axis.
95. Microbiota and Neurodevelopmental Trajectories: Role of Maternal and Early-
Life Nutrition.
96. Bile acid is a significant host factor shaping the gut microbiome of diet-
induced obese mice.
97. Bile Acid Supplementation Improves Murine Pancreatitis in Association With
the Gut Microbiota.
98. Growth promotion and gut microbiota: insights from antibiotic use.
99. Stress and the Microbiota-Gut-Brain Axis: An Evolving Concept in Psychiatry.
100. Comorbidity between depression and inflammatory bowel disease explained
by immune-inflammatory, oxidative, and nitrosative stress; tryptophan
catabolite; and gut-brain pathways.
101. Prebiotic intake reduces the waking cortisol response and alters emotional
bias in healthy volunteers.
102. Gut microbiota alterations and dietary modulation in childhood malnutrition -
The role of short chain fatty acids.
103. Decreased maternal serum acetate and impaired fetal thymic and regulatory T
cell development in preeclampsia.
104. Paneth Cell Alertness to Pathogens Maintained by Vitamin D Receptors.
105. The Gut Microbiota: A Promising Target in the Relation between
Complementary Feeding and Child Undernutrition.
106. Danggui Buxue Tang restores antibiotic-induced metabolic disorders by
remodeling the gut microbiota.
107. A diet-microbial metabolism feedforward loop modulates intestinal stem cell
renewal in the stressed gut.
108. The MAL-ED study: a multinational and multidisciplinary approach to
understand the relationship between enteric pathogens, malnutrition, gut
physiology, physical growth, cognitive development, and immune responses
in infants and children up to 2 years of age in resource-poor environments.
109. Staphylococcus aureus and the Cutaneous Microbiota Biofilms in the
Pathogenesis of Atopic Dermatitis.
110. Neohesperidin attenuates obesity by altering the composition of the
gut microbiota in high-fat diet-fed mice.
111. Environmental Enteric Dysfunction and the Fecal Microbiota in Malawian
Children.
112. Vertical transmission of gut microbiota: Points of action of environmental
factors influencing brain development.
113. [Human Intestinal Microbiota: Role in Development and Functioning of the
Nervous System].
114. The effects of inflammation, infection and antibiotics on the microbiota-gut-
brain axis.
115. Plant extracts as natural modulators of gut microbiota community structure
and functionality.
116. Dietary iron variably modulates assembly of the intestinal microbiota in
colitis-resistant and colitis-susceptible mice.
117. Antibiotics in early life and obesity.
118. Fat-Shaped Microbiota Affects Lipid Metabolism, Liver Steatosis, and
Intestinal Homeostasis in Mice Fed a Low-Protein Diet.
119. Prebiotics and Community Composition Influence Gas Production of the
Human Gut Microbiota.
120. Does gut microbiome associate with the growth of infants? A review of the
literature.
121. Alterations in the Urinary Microbiota Are Associated With Cesarean Delivery.
122. Berberine treatment increases Akkermansia in the gut and improves high-fat
diet-induced atherosclerosis in Apoe-/- mice.
123. At the Intersection of Microbiota and Circadian Clock: Are Sexual Dimorphism
and Growth Hormones the Missing Link to Pathology?: Circadian Clock
and Microbiota: Potential Egffect on Growth Hormone and Sexual
Development.
124. Bile acid sequestration reverses liver injury and prevents progression of
nonalcoholic steatohepatitis in Western diet-fed mice.
125. Disrupted tongue microbiota and detection of nonindigenous bacteria on the
day of allogeneic hematopoietic stem cell transplantation.
126. Gut microbiota: Growth impairment in undernourished children.
127. Mushrooms Bioactive as Prebiotics to Modulate Gut Microbiota in
Relationships with Causes and Prevention of Liver Diseases (Review).
128. Dysbiosis in Functional Bowel Disorders.
129. Gut Microbiome and Infant Health: Brain-Gut-Microbiota Axis and Host
Genetic Factors.
130. Gut microbiota of newborn piglets with intrauterine growth restriction have
lower diversity and different taxonomic abundances.
131. [Characterization of the microbiota and cytokine profile of sperm plasma in
men with chronic bacterial prostatitis].
132. Gut Microbiota Features Associated With Campylobacter Burden and
Postnatal Linear Growth Deficits in a Peruvian Birth Cohort.
133. Giardia duodenalis induces pathogenic dysbiosis of human
intestinal microbiota biofilms.
134. Overview of paediatric IBD.
135. Stunting Is Preceded by Intestinal Mucosal Damage and Microbiome Changes
and Is Associated with Systemic Inflammation in a Cohort of Peruvian Infants.
136. Longitudinal Analysis of the Intestinal Microbiota in
Persistently Stunted Young Children in South India.
137. A distinct gut microbiota composition in patients with ankylosing spondylitis
is associated with increased levels of fecal calprotectin.
138. Association of faecal pH with childhood stunting: Results from a cross-
sectional study.
139. Gut microbiota controls adipose tissue expansion, gut barrier and glucose
metabolism: novel insights into molecular targets and interventions using
prebiotics.
140. Identifying the etiology and pathophysiology underlying stunting and
environmental enteropathy: study protocol of the AFRIBIOTA project.
141. [Mechanism of gut-microbiota-liver axis in the pathogenesis of intestinal
failure-associated liver disease].
142. Inflammatory bowel disease: role of diet, microbiota, life style.
143. Contextual risk factors impacting the colonization and development of the
intestinal microbiota: Implications for children in low- and middle-income
countries.
144. Possibilities of early life programming in broiler chickens via
intestinal microbiota modulation.
145. Microbial and nutritional influence on endocrine control of growth.
146. Bacteriophages Isolated from Stunted Children Can Regulate Gut Bacterial
Communities in an Age-Specific Manner.
147. Mechanisms and effectiveness of prebiotics in modifying the
gastrointestinal microbiota for the management of digestive disorders.
148. MAVS deficiency induces gut dysbiotic microbiota conferring a proallergic
phenotype.
149. Environmental Chemical Diethylhexyl Phthalate Alters
Intestinal Microbiota Community Structure and Metabolite Profile in Mice.
150. Long-term Proton Pump Inhibitor Administration Caused Physiological
and Microbiota Changes in Rats.
151. Host Immunity to Malassezia in Health and Disease.
152. Oesophageal atresia: The growth gap.
153. Impact of vitamin deficiency on microbiota composition and
immunomodulation: relevance to autistic spectrum disorders.
154. The Gut Microbiome in Child Malnutrition.
155. Stable Isotope Techniques for the Assessment of Host
and Microbiota Response During Gastrointestinal Dysfunction.
156. Huai hua san alleviates dextran sulphate sodium-induced colitis and
modulates colonic microbiota.
157. The Physiology and Mechanism of Growth.
158. Microbiota-derived lipopolysaccharide retards chondrocyte hypertrophy in
the growth plate through elevating Sox9 expression.
159. Study of the fetal and maternal microbiota in pregnant women with
intrauterine growth restriction and its relationship with inflammatory
biomarkers: A case-control study protocol (SPIRIT compliant).
160. Composition of gut microbiota in infants in China and global comparison.
161. Rice bran supplementation modulates growth, microbiota and metabolome
in weaning infants: a clinical trial in Nicaragua and Mali.
162. Phytohormones: Multifunctional nutraceuticals against metabolic syndrome
and comorbid diseases.
163. A Retrospective Case-Control Study of the Relationship between the
Gut Microbiota, Enteropathy, and Child Growth.
164. The Microbiota-Gut-Brain Axis: From Motility to Mood.
165. The gut microbiome.
166. Lactobacillus plantarum NA136 ameliorates nonalcoholic fatty liver disease by
modulating gut microbiota, improving intestinal barrier integrity, and
attenuating inflammation.
167. Assessment of Neonatal Intensive Care Unit Practices and Preterm Newborn
Gut Microbiota and 2-Year Neurodevelopmental Outcomes.
168. The role of prebiotics in cognition, anxiety, and depression.
169. Intestinal Microbiota in Common Chronic Inflammatory Disorders Affecting
Children.
170. Gut microbiota profile of Indonesian stunted children and children with
normal nutritional status.
171. Absence of gut microbiota influences lipopolysaccharide-induced behavioral
changes in mice.
172. Could the beneficial effects of dietary calcium on obesity and diabetes control
be mediated by changes in intestinal microbiota and integrity?
173. Effects of subchronic exposure of mercuric chloride on intestinal histology
and microbiota in the cecum of chicken.
174. Gut Microbiota and Bipolar Disorder: An Overview on a Novel Biomarker for
Diagnosis and Treatment.
175. Modulation of Placental Gene Expression in Small-for-Gestational-Age Infants.
176. Fructose malabsorption syndrome.
177. New insights into environmental enteric dysfunction.
178. Environmental enteric dysfunction and growth.
179. Green Tea Encourages Growth of Akkermansia muciniphila.
180. Bacteriophages in food supplements obtained from natural sources.
181. Peripheral aetiopathogenic drivers and mediators of Parkinson's disease and
co-morbidities: role of gastrointestinal microbiota.
182. Amino Acids Regulate Glycolipid Metabolism and Alter Intestinal Microbial
Composition.
183. Analysis of temporal fecal microbiota dynamics in weaner pigs with and
without exposure to enterotoxigenic Escherichia coli1,2.
184. Proof-of-concept study of the efficacy of a microbiota-directed
complementary food formulation (MDCF) for treating moderate acute
malnutrition.
185. Aflatoxins: Occurrence, Exposure, and Binding to Lactobacillus Species from
the Gut Microbiota of Rural Ugandan Children.
186. Malnutrition and Catch-Up Growth during Childhood and Puberty.
187. Severe gut microbiota dysbiosis caused by malnourishment can be partly
restored during 3 weeks of refeeding with fortified corn-soy-blend in a piglet
model of childhood malnutrition.
188. Dysbiotic microbiota in autistic children and their mothers: persistence of
fungal and bacterial wall-deficient L-form variants in blood.
189. Maternal and infant factors that shape neonatal gut colonization by bacteria.
190. Decoding breast milk oligosaccharides.
191. Can we reduce autism-related gastrointestinal and behavior problems by
gut microbiota based dietary modulation? A review.
192. CBirTox is a selective antigen-specific agonist of the Treg-IgA-
microbiota homeostatic pathway.
193. The impact of in utero HIV exposure on gut microbiota, inflammation, and
microbial translocation.
194. Alginate oligosaccharide improves lipid metabolism and inflammation by
modulating gut microbiota in high-fat diet fed mice.
195. Compound Lactobacillus sp. administration ameliorates stress and
body growth through gut microbiota optimization on weaning piglets.
196. Immunoglobulin recognition of fecal bacteria in stunted and non-
stunted children: findings from the Afribiota study.
197. [The value of mucosal small intestine microbiota in digestion and
absorption disorders in metabolic syndrome].
198. The protective effects of walnut green husk polysaccharide on liver injury,
vascular endothelial dysfunction and disorder of gut microbiota in high
fructose-induced mice.
199. Sialylated Milk Oligosaccharides Promote Microbiota-Dependent Growth in
Models of Infant Undernutrition.
200. What's eating you? An update on Giardia, the microbiome and the immune
response.
201. Mechanisms of obesity-induced gastrointestinal neoplasia.
202. Malnutrition and Catch-Up Growth during Childhood and Puberty.
203. Inflammation and the microbiome: implications for depressive disorders.
204. Environmental enteric dysfunction: an overview.
205. Small Intestinal Bacterial Overgrowth and Other Intestinal Disorders.
206. Childhood malnutrition and the intestinal microbiome.
207. beta-Carotene prevents weaning-induced intestinal inflammation by
modulating gut microbiota in piglets.
208. Evolution, human-microbe interactions, and life history plasticity.
209. Effects of the acid-base treatment of corn on rumen fermentation
and microbiota, inflammatory response and growth performance in beef
cattle fed high-concentrate diet.
210. Microbiome programming of brain development: implications for
neurodevelopmental disorders.
211. Effects of a Synbiotic Formula on Functional Bowel Disorders and
Gut Microbiota Profile during Long-Term Home Enteral Nutrition (LTHEN): A
Pilot Study.
212. Potential Impacts of Prebiotics and Probiotics in Cancer Prevention.
213. Lactobacillus casei improves depression-like behavior in chronic unpredictable
mild stress-induced rats by the BDNF-TrkB signal pathway and the
intestinal microbiota.
214. Microbiome, growth retardation and metabolism: are they related?
215. Host-microbe interactions via membrane transport systems.
216. Early-Life Nutrition and Microbiome Development.
217. Characteristics of the gut microbiota colonization, inflammatory profile, and
plasma metabolome in intrauterine growth restricted piglets during the first
12 hours after birth.
218. Gut microbiota profiles of young South Indian children: Child sex-specific
relations with growth.
219. Does the Oral Microbiome Play a Role in Hypertensive Pregnancies?
220. Participation of the intestinal microbiota in the mechanism of beneficial effect
of treatment with synbiotic Syngut on experimental colitis under stress
conditions.
221. Ganoderic acid A from Ganoderma lucidum ameliorates lipid metabolism and
alters gut microbiota composition in hyperlipidemic mice fed a high-fat diet.
222. Polyphenols as modulators of pre-established gut microbiota dysbiosis:
State-of-the-art.
223. The immunomodulatory role of bile acids.
224. Pig models on intestinal development and therapeutics.
225. Emerging issues in complementary feeding: Global aspects.
226. Gut microbiota varies by opioid use, circulating leptin and oxytocin in African
American men with diabetes and high burden of chronic disease.
227. Microbiome: An Emerging New Frontier in Graft-Versus-Host Disease.
228. Implication of gut microbiota in human health.
229. In vitro modulation of gut microbiota by whey protein to preserve intestinal
health.
230. Modulating the microbiota in inflammatory bowel diseases: prebiotics,
probiotics or faecal transplantation?
231. Emulating Host-Microbiome Ecosystem of Human Gastrointestinal Tract in
Vitro.
232. Fecal microbiota analysis of children with small intestinal bacterial overgrowth
among residents of an urban slum in Brazil.
233. Linear growth faltering in infants is associated with Acidaminococcus sp. and
community-level changes in the gut microbiota.
234. Gut biofilm forming bacteria in inflammatory bowel disease.
235. Bacterial skin commensals and their role as host guardians.
236. The gut microflora assay in patients with colorectal cancer: in feces or tissue
samples?
237. Current Understanding of Innate Immune Cell Dysfunction in Childhood
Undernutrition.
238. Voices from within: gut microbes and the CNS.
239. Duodenal Microbiota in Stunted Undernourished Children with Enteropathy.
Reply.
240. Microbiomes Reduce Their Host's Sensitivity to Interspecific Interactions.
241. Maternal administration of probiotics promotes gut development in mouse
offsprings.
242. Duodenal Microbiota in Stunted Undernourished Children with Enteropathy.
243. Duodenal Microbiota in Stunted Undernourished Children with Enteropathy.
244. Severe Gut Microbiota Dysbiosis Is Associated With Poor Growth in Patients
With Short Bowel Syndrome.
245. Developments in the study of gastrointestinal microbiome disorders affected
by FGF19 in the occurrence and development of colorectal neoplasms.
246. Loss of PTPN22 abrogates the beneficial effect of cohousing-mediated
fecal microbiota transfer in murine colitis.
247. [INFECTIOUS SYMBIOLOGY].
248. Microbiome: Eating for trillions.
249. Beneficial Effects of Non-Encapsulated or Encapsulated Probiotic
Supplementation on Microbiota Composition, Intestinal Barrier Functions,
Inflammatory Profiles, and Glucose Tolerance in High Fat Fed Rats.
250. Astaxanthin (ATX) enhances the intestinal mucosal functions in
immunodeficient mice.
251. Bile acid-based therapies for non-alcoholic steatohepatitis and alcoholic liver
disease.
252. Gut microbiota dysbiosis is associated with malnutrition and reduced plasma
amino acid levels: Lessons from genome-scale metabolic modeling.
253. Scalp bacterial shift in Alopecia areata.
254. Age-associated Impairment of the Mucus Barrier Function is Associated with
Profound Changes in Microbiota and Immunity.
255. Role of the Gastrointestinal Tract Microbiome in the Pathophysiology of
Diabetes Mellitus.
256. Lactococcus lactis and Resveratrol Decrease Body Weight and Increase Benefic
Gastrointestinal Microbiota in Mice.
257. Helicobacter pylori and its relationship with variations of gut microbiota in
asymptomatic children between 6 and 12 years.
258. Microbiota control of maternal behavior regulates early postnatal growth of
offspring.
259. The role of the gut microbiome in mediating neurotoxic outcomes to PCB
exposure.
260. Assessment of the adverse impacts of aflatoxin B(1) on gut-
microbiota dependent metabolism in F344 rats.
261. Early-life enteric infections: relation between chronic systemic inflammation
and poor cognition in children.
262. Food restriction followed by refeeding with a casein- or whey-based diet
differentially affects the gut microbiota of pre-pubertal male rats.
263. The impact of Helicobacter pylori infection on gut microbiota-endocrine
system axis; modulation of metabolic hormone levels and energy homeostasis.
264. What's in the pipeline for lower functional gastrointestinal disorders in the
next 5 years?
265. Bacteriocins and bacteriophage; a narrow-minded approach to food and gut
microbiology.
266. Gut Microbiota Disorders Promote Inflammation and Aggravate Spinal Cord
Injury Through the TLR4/MyD88 Signaling Pathway.
267. Finding intestinal fortitude: Integrating the microbiome into a holistic view of
depression mechanisms, treatment, and resilience.
268. Medicinal lavender modulates the enteric microbiota to protect against
Citrobacter rodentium-induced colitis.
269. Mechanisms of cross-talk between the diet, the intestinal microbiome, and the
undernourished host.
270. Changes in microbial ecology after fecal microbiota transplantation for
recurrent C. difficile infection affected by underlying inflammatory bowel
disease.
271. Differences in the Gut Microbiota Establishment and Metabolome
Characteristics Between Low- and Normal-Birth-Weight Piglets During Early-
Life.
272. [Changes in the composition of intestinal microbiota in mice with acute liver
failure induced by D-galactosamine].
273. Bacterial Diversity of Intestinal Microbiota in Patients with Substance
Use Disorders Revealed by 16S rRNA Gene Deep Sequencing.
274. [Role of the microbiome in chronic wounds].
275. Early development of the gut microbiome and immune-mediated
childhood disorders.
276. Animal Models of Undernutrition and Enteropathy as Tools for Assessment of
Nutritional Intervention.
277. Role of Gut Microbiota, Probiotics and Prebiotics in the Cardiovascular
Diseases.
278. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in
response of colocytes.
279. Enduring Behavioral Effects Induced by Birth by Caesarean Section in the
Mouse.
280. Sulfated polysaccharides from Undaria pinnatifida improved high fat diet-
induced metabolic syndrome, gut microbiota dysbiosis and inflammation in
BALB/c mice.
281. Overgrowth of the indigenous gut microbiome and irritable bowel syndrome.
282. Biomarkers to Stratify Risk Groups among Children with Malnutrition in
Resource-Limited Settings and to Monitor Response to Intervention.
283. Neonatal environment exerts a sustained influence on the development of the
intestinal microbiota and metabolic phenotype.
284. Effect of prebiotic and probiotic supplementation on neurodevelopment in
preterm very low birth weight infants: findings from a meta-analysis.
285. Arc1 and the microbiota together modulate growth and metabolic traits in
Drosophila.
286. Microbiota-Gut-Brain Axis: Yeast Species Isolated from Stool Samples of
Children with Suspected or Diagnosed Autism Spectrum Disorders and In
Vitro Susceptibility Against Nystatin and Fluconazole.
287. Eosinophils in Homeostasis and Their Contrasting Roles during Inflammation
and Helminth Infections.
288. Lysosome-Rich Enterocytes Mediate Protein Absorption in the Vertebrate Gut.
289. Hygiene and other early childhood influences on the subsequent function of
the immune system.
290. Ginseng ameliorates exercise-induced fatigue potentially by regulating the
gut microbiota.
291. Early-life adversity and brain development: Is the microbiome a missing piece
of the puzzle?
292. Metabolic tinkering by the gut microbiome: Implications for brain
development and function.
293. Antibiotic-Induced Alterations of the Gut Microbiota Alter Secondary Bile
Acid Production and Allow for Clostridium difficile Spore Germination and
Outgrowth in the Large Intestine.
294. Pasteurized Akkermansia muciniphila protects from fat mass gain but not from
bone loss.
295. An introduction of the role of probiotics in human infections and autoimmune
diseases.
296. The human microbiome and the great obstetrical syndromes: a new frontier in
maternal-fetal medicine.
297. Dental biofilm and its ecological interrelationships in ovine periodontitis.
298. Microbes & neurodevelopment--Absence of microbiota during early life
increases activity-related transcriptional pathways in the amygdala.
299. The inflammatory event of birth: How oxytocin signaling may guide the
development of the brain and gastrointestinal system.
300. Microbial Impact on Host Metabolism: Opportunities for Novel Treatments of
Nutritional Disorders?
301. Intergenerational Influences between Maternal Polycystic Ovary Syndrome
and Offspring: An Updated Overview.
302. Prebiotics and probiotics: their role in the management of
gastrointestinal disorders in adults.
303. Diarrhea as a Potential Cause and Consequence of Reduced Gut Microbial
Diversity Among Undernourished Children in Peru.
304. Dietary Lactobacillus plantarum ST-III alleviates the toxic effects of triclosan on
zebrafish (Danio rerio) via gut microbiota modulation.
305. 3-(4-Hydroxy-3-methoxyphenyl)propionic Acid Produced from 4-Hydroxy-3-
methoxycinnamic Acid by Gut Microbiota Improves Host Metabolic Condition
in Diet-Induced Obese Mice.
306. Nanoplastics impair the intestinal health of the juvenile large yellow croaker
Larimichthys crocea.
307. Biological significance of short-chain fatty acid metabolism by the intestinal
microbiome.
308. Transforming growth factor and intestinal inflammation: the role of nutrition.
309. Colonization with the enteric protozoa Blastocystis is associated with
increased diversity of human gut bacterial microbiota.
310. Impact of Flavonoids on Cellular and Molecular Mechanisms Underlying Age-
Related Cognitive Decline and Neurodegeneration.
311. Huangjinya Black Tea Alleviates Obesity and Insulin Resistance via Modulating
Fecal Metabolome in High-Fat Diet-Fed Mice.
312. An evolving perspective about the origins of childhood undernutrition and
nutritional interventions that includes the gut microbiome.
313. Antibiotic-mediated modification of the intestinal microbiome in allogeneic
hematopoietic stem cell transplantation.
314. Diagnosis of small intestinal bacterial overgrowth in the clinical practice.
315. Gut microbiota: stunted gut microbiota development persists after
therapeutic food interventions in children with severe acute malnutrition.
316. Effects of Dietary Interventions on Gut Microbiota in Humans and the
Possible Impacts of Foods on Patients' Responses to Cancer Immunotherapy.
317. Production of germ-free mosquitoes via transient colonisation allows stage-
specific investigation of host-microbiota interactions.
318. Fat binding capacity and modulation of the gut microbiota both determine
the effect of wheat bran fractions on adiposity.
319. Microbial insight into dietary protein source affects intestinal function of pigs
with intrauterine growth retardation.
320. Could Nodding Syndrome (NS) in Northern Uganda be an environmentally
induced alteration of ancestral microbiota?
321. Microbiome: Restoring healthy growth in infants.
322. Radiomicrobiomics: Advancing Along the Gut-brain Axis Through Big Data
Analysis.
323. Growth velocity in children with Environmental Enteric Dysfunction is
associated with specific bacterial and viral taxa of the gastrointestinal tract in
Malawian children.
324. IgA synthesis: a form of functional immune adaptation extending beyond gut.
325. Campylobacter jejuni and associated immune mechanisms: short-term effects
and long-term implications for infants in low-income countries.
326. Evidence-based interventions for improvement of maternal and child nutrition
in low-income settings: what's new?
327. [Microbiota of urine and vagina of healthy postmenopausal women (a pilot
study)].
328. The New Era of Treatment for Obesity and Metabolic Disorders: Evidence and
Expectations for Gut Microbiome Transplantation.
329. Neonatal Enteropathogenic Escherichia coli Infection Disrupts Microbiota-
Gut-Brain Axis Signaling.
330. Amino acid metabolism in intestinal bacteria and its potential implications for
mammalian reproduction.
331. Impact of dietary induced precocious gut maturation on cecal microbiota and
its relation to the blood-brain barrier during the postnatal period in rats.
332. Markers of Environmental Enteric Dysfunction Are Associated with
Poor Growth and Iron Status in Rural Ugandan Infants.
333. Recipe for a Healthy Gut: Intake of Unpasteurised Milk Is Associated with
Increased Lactobacillus Abundance in the Human Gut Microbiome.
334. Fecal dysbiosis in infants with cystic fibrosis is associated with early
linear growth failure.
335. Common beans and cowpeas as complementary foods to reduce
environmental enteric dysfunction and stunting in Malawian children: study
protocol for two randomized controlled trials.
336. Lactobacillus plantarum NCU116 attenuates cyclophosphamide-induced
intestinal mucosal injury, metabolism and intestinal microbiota disorders in
mice.
337. Interactions of Dietary Fibre with Nutritional Components on Gut Microbial
Composition, Function and Health in Monogastrics.
338. Review: Mouse models of inflammatory bowel disease--insights into the
mechanisms of inflammation-associated colorectal cancer.
339. Sex dependent effects of post-natal penicillin on brain, behavior and immune
regulation are prevented by concurrent probiotic treatment.
340. Mechanisms by which sialylated milk oligosaccharides impact bone biology in
a gnotobiotic mouse model of infant undernutrition.
341. Lactobacillus rhamnosus Granules Dose-Dependently Balance Intestinal
Microbiome Disorders and Ameliorate Chronic Alcohol-Induced Liver Injury.
342. Intestinal Dysbiosis Correlates With Sirolimus-induced Metabolic Disorders in
Mice.
343. Dysregulated Gut Homeostasis Observed Prior to the Accumulation of the
Brain Amyloid-β in Tg2576 Mice.
344. The effect of dietary resistant starch type 2 on the microbiota and markers of
gut inflammation in rural Malawi children.
345. Cationic Polystyrene Resolves Nonalcoholic Steatohepatitis, Obesity, and
Metabolic Disorders by Promoting Eubiosis of Gut Microbiota and
Decreasing Endotoxemia.
346. Microbiome. The right gut microbes help infants grow.
347. Metabolome and microbiome alterations related to short-term feeding of a
micronutrient-fortified, high-quality legume protein-based food product
to stunted school age children: A randomized controlled pilot trial.
348. Red pitaya betacyanins protects from diet-induced obesity, liver steatosis and
insulin resistance in association with modulation of gut microbiota in mice.
349. Co-occurrence of Campylobacter Species in Children From Eastern Ethiopia,
and Their Association With Environmental Enteric Dysfunction, Diarrhea, and
Host Microbiome.
350. Early life nutrition influences susceptibility to chronic inflammatory colitis in
later life.
351. The Double Burden of Malnutrition Calls for Better Diet Quality Worldwide.
352. Plant Prebiotics and Their Role in the Amelioration of Diseases.
353. Developmental exposure of California mice to endocrine disrupting chemicals
and potential effects on the microbiome-gut-brain axis at adulthood.
354. TNFR2 Deficiency Acts in Concert with Gut Microbiota To Precipitate
Spontaneous Sex-Biased Central Nervous System Demyelinating Autoimmune
Disease.
355. Trace metals and animal health: Interplay of the gut microbiota with iron,
manganese, zinc, and copper.
356. A mixture of trans-galactooligosaccharides reduces markers of metabolic
syndrome and modulates the fecal microbiota and immune function of
overweight adults.
357. The "systems approach" to treating the brain: opportunities in developmental
psychopharmacology.
358. Dietary soybean protein concentrate-induced intestinal disorder in marine
farmed Atlantic salmon, Salmo salar is associated with alterations in
gut microbiota.
359. Lactobacillus rhamnosus lowers zebrafish lipid content by changing
gut microbiota and host transcription of genes involved in lipid metabolism.
360. Effects of synbiotic supplementation on gut microbiome, serum level of TNF-
α, and expression of microRNA-126 and microRNA-146a in patients with type
2 diabetes mellitus: study protocol for a double-blind controlled randomized
clinical trial.
361. Bifidobacterium longum subsp. longum Remodeled Roseburia and
Phosphatidylserine Levels and Ameliorated Intestinal Disorders and liver
Metabolic Abnormalities Induced by High-Fat Diet.
362. Endocrine disrupting chemicals and metabolic disorders in the liver: What if
we also looked at the female side?
363. Predictive Metagenomic Profiling, Urine Metabolomics, and Human Marker
Gene Expression as an Integrated Approach to Study Alopecia Areata.
364. Cognitive and Microbiome Impacts of Experimental Ancylostoma ceylanicum
Hookworm Infections in Hamsters.
365. Feed intake limitation strategies for the growing rabbit: effect on feeding
behaviour, welfare, performance, digestive physiology and health: a review.
366. Effects of the Cistanche tubulosa Aqueous Extract on the Gut Microbiota of
Mice with Intestinal Disorders.
367. Dietary Cellulose Supplementation Modulates the Immune Response in a
Murine Endotoxemia Model.
368. Inflammatory Bowel Disease: Effects on Bone and Mechanisms.
369. Association between extrauterine growth restriction and changes of intestinal
flora in Chinese preterm infants.
370. Efficacy of Postbiotics in a PRP-Like Cosmetic Product for the Treatment of
Alopecia Area Celsi: A Randomized Double-Blinded Parallel-Group Study.
371. Curcumin alleviates high-fat diet-induced hepatic steatosis and obesity in
association with modulation of gut microbiota in mice.
372. N-Acetylcysteine alleviates gut dysbiosis and glucose metabolic disorder in
high-fat diet-fed mice.
373. Subtle selectivity in a pheromone sensor triumvirate desynchronizes
competence and predation in a human gut commensal.
374. The intestinal virome of malabsorption syndrome-affected and unaffected
broilers through shotgun metagenomics.
375. Intestinal response characteristic and potential microbial dysbiosis in digestive
tract of Bufo gargarizans after exposure to cadmium and lead, alone or
combined.
376. Pediatric small intestine bacterial overgrowth in low-income countries.
377. The probiotic Lactobacillus fermentum 296 attenuates
cardiometabolic disorders in high fat diet-treated rats.
378. Pathobiome driven gut inflammation in Pakistani children with Environmental
Enteric Dysfunction.
379. Adolescent diabetes induced by multiple parental exposures to cigarette
smoke condensate.
380. Examination of Host Phenotypes in Gambusia affinis Following Antibiotic
Treatment.
381. High-methionine diet in skeletal muscle remodeling: epigenetic mechanism of
homocysteine-mediated growth retardation.
382. It's in the Milk: Feeding the Microbiome to Promote Infant Growth.
383. Vitamin D Signaling through Induction of Paneth Cell Defensins Maintains
Gut Microbiota and Improves Metabolic Disorders and Hepatic Steatosis in
Animal Models.
384. Comprehensive Bibliometric Analysis of the Kynurenine Pathway in
Mood Disorders: Focus on Gut Microbiota Research.
385. The Influence of Cesarean Section on the Composition and Development of
Gut Microbiota During the First 3 Months of Life.
386. Impact of feed restriction on health, digestion and faecal microbiota of
growing pigs housed in good or poor hygiene conditions.
387. Involvement of Smad7 in Inflammatory Diseases of the Gut and Colon Cancer.
388. Contribution of "Omic" Studies to the Understanding of Cadasil. A Systematic
Review.
389. Smad7 in intestinal CD4+ T cells determines autoimmunity in a spontaneous
model of multiple sclerosis.
390. Intestinal dysbiosis: an emerging cause of pregnancy complications?
391. Bacterial Succession in the Broiler Gastrointestinal Tract.
392. The effect of bovine colostrum/egg supplementation compared with corn/soy
flour in young Malawian children: a randomized, controlled clinical trial.
393. Potential role of weather, soil and plant microbial communities in rapid decline
of apple trees.
394. Modulatory Effects of Probiotics During Pathogenic Infections With Emphasis
on Immune Regulation.
395. An Exposome Perspective on Environmental Enteric Dysfunction.
396. Effects of maize rotation on the physicochemical properties and microbial
communities of American ginseng cultivated soil.
397. Effects of dietary supplementation of selenium-enriched probiotics on
production performance and intestinal microbiota of weanling piglets raised
under high ambient temperature.
398. Bacterial sensing underlies artificial sweetener-induced growth of gut
Lactobacillus.
399. Intestinal fluke Metagonimus yokogawai infection increases probiotic
Lactobacillus in mouse cecum.
400. Polysaccharides from fermented Momordica charantia L. with Lactobacillus
plantarum NCU116 ameliorate metabolic disorders and
gut microbiota change in obese rats.
401. Chinese liver fluke Clonorchis sinensis infection changes the gut microbiome
and increases probiotic Lactobacillus in mice.
402. Relative abundance of Akkermansia spp. and other bacterial phylotypes
correlates with anxiety- and depressive-like behavior following social defeat in
mice.
403. Effect of Native and Acetylated Dietary Resistant Starches on Intestinal
Fermentative Capacity of Normal and Stunted Children in Southern India.
404. Postnatal growth retardation is associated with deteriorated intestinal
mucosal barrier function using a porcine model.
405. Fetal exposure to maternal inflammation interrupts murine intestinal
development and increases susceptibility to neonatal intestinal injury.
406. Is small intestinal bacterial overgrowth involved in the pathogenesis of
functional dyspepsia?
407. Astragalus Polysaccharides Ameliorate Diet-Induced Gallstone Formation by
Modulating Synthesis of Bile Acids and the Gut Microbiota.
408. Lactobacillus fermentum NS9 restores the antibiotic induced physiological and
psychological abnormalities in rats.
409. Akkermansia muciniphila strain ATCC BAA-835 does not promote short-term
intestinal inflammation in gnotobiotic interleukin-10-deficient mice.
410. Lack of Small Intestinal Dysbiosis Following Long-Term Selective Inhibition of
Cyclooxygenase-2 by Rofecoxib in the Rat.
411. Guadipyr, a new insecticide, induces microbiota dysbiosis and
immune disorders in the midgut of silkworms (Bombyx mori).
412. Physiological and Metabolic Effects of Yellow Mangosteen (Garcinia dulcis)
Rind in Rats with Diet-Induced Metabolic Syndrome.
413. Plant and Animal-Type Feedstuff Shape the Gut Microbiota and Metabolic
Processes of the Chinese Mitten Crab Eriocheir sinensis.
414. Intestinal nerve cell injury occurs prior to insulin resistance in female mice
ingesting a high-fat diet.
415. Influence of Socio-Economic and Psychosocial Profiles on the Human Breast
Milk Bacteriome of South African Women.
416. Significance of African Diets in Biotherapeutic Modulation of the Gut
Microbiome.
417. Study of Environmental Enteropathy and Malnutrition (SEEM) in Pakistan:
protocols for biopsy based biomarker discovery and validation.
418. Size-dependent adverse effects of microplastics on intestinal microbiota and
metabolic homeostasis in the marine medaka (Oryzias melastigma).
419. Anxiety-like behavior and intestinal microbiota changes as strain-and sex-
dependent sequelae of mild food allergy in mouse models of cow's milk
allergy.
420. Polyphenol-rich extract of pomegranate peel alleviates tissue inflammation
and hypercholesterolaemia in high-fat diet-induced obese mice: potential
implication of the gut microbiota.
421. The effect of antibiotics on social aversion following early life inflammation.
422. Early-life high-fat diet-induced obesity programs hippocampal development
and cognitive functions via regulation of gut commensal Akkermansia
muciniphila.
423. The composition and structure of the intestinal microflora of Anguilla
marmorata at different growth rates: a deep sequencing study.
424. Alterations in the Vaginal Microbiome by Maternal Stress Are Associated With
Metabolic Reprogramming of the Offspring Gut and Brain.
425. Lysozyme-rich milk mitigates effects of malnutrition in a pig model of
malnutrition and infection.
426. Preparation and preservation of viable Akkermansia muciniphila cells for
therapeutic interventions.
427. Increased Urinary Trimethylamine N-Oxide Following Cryptosporidium
Infection and Protein Malnutrition Independent of Microbiome Effects.
428. Effects of dietary Lactobacillus rhamnosus JCM1136 and Lactococcus lactis
subsp. lactis JCM5805 on the growth, intestinal microbiota, morphology,
immune response and disease resistance of juvenile Nile tilapia, Oreochromis
niloticus.
429. Prebiotics for Lactose Intolerance: Variability in Galacto-Oligosaccharide
Utilization by Intestinal Lactobacillus rhamnosus.
430. Perturbations of gut microbiome genes in infants with atopic dermatitis
according to feeding type.
431. Dietary modulation of the microbiome affects autoinflammatory disease.
432. The critical roles of iron during the journey from fetus to adolescent:
Developmental aspects of iron homeostasis.
433. Stunted childhood growth is associated with decompartmentalization of the
gastrointestinal tract and overgrowth of oropharyngeal taxa.
434. Bifidobacterium infantis M-63 improves mental health in victims with irritable
bowel syndrome developed after a major flood disaster.
435. Generation of axenic Aedes aegypti demonstrate live bacteria are not required
for mosquito development.
436. Assessment of Environmental Enteric Dysfunction in the SHINE Trial: Methods
and Challenges.
437. Etiology of Diarrhea, Nutritional Outcomes, and Novel Intestinal Biomarkers in
Tanzanian Infants.
438. Maternal Weaning Modulates Emotional Behavior and Regulates the Gut-Brain
Axis.
439. Effect of cryopreservation and lyophilization on viability and growth of strict
anaerobic human gut microbes.
440. Flaxseed oil supplementation improves intestinal function and immunity,
associated with altered intestinal microbiome and fatty acid profile in pigs
with intrauterine growth retardation.
441. Antioxidant properties of formula derived Maillard reaction products in colons
of intrauterine growth restricted pigs.
442. The Impact of Gut Microbiome on Metabolic Disorders During Catch-
Up Growth in Small-for-Gestational-Age.
443. Chronic consequences on human health induced by microbial
pathogens: Growth faltering among children in developing countries.
444. Faecalibacterium prausnitzii (ATCC 27766) has preventive and therapeutic
effects on chronic unpredictable mild stress-induced depression-like and
anxiety-like behavior in rats.
445. From pre- to postweaning: Transformation of the young calf's gastrointestinal
tract.
446. Environmental characteristics of a tundra river system in Svalbard. Part 2:
Chemical stress factors.
447. Adaptation of commensal proliferating Escherichia coli to the intestinal tract of
young children with cystic fibrosis.
448. Adverse effect of early-life high-fat/high-carbohydrate ("Western") diet on
bacterial community in the distal bowel of mice.
449. Gutting the brain of inflammation: A key role of gut microbiome in human
umbilical cord blood plasma therapy in Parkinson's disease model.
450. The Role of Gut Bacterial Metabolites in Brain Development, Aging and
Disease.
451. Nurturing gut-brain research: an interview with Helen Vuong on the maternal
microbiome in neurodevelopment.
452. A postbiotic consisting of heat-treated lactobacilli has a bifidogenic effect in
pure culture and in human fermented faecal communities.
453. n-6 High Fat Diet Induces Gut Microbiome Dysbiosis and Colonic
Inflammation.
454. Remnant Small Bowel Length in Pediatric Short Bowel Syndrome and the
Correlation with Intestinal Dysbiosis and Linear Growth.
455. Effects of Subchronic Copper Poisoning on Cecal Histology and Its Microflora
in Chickens.
456. Risk factors for noma disease: a 6-year, prospective, matched case-control
study in Niger.
457. [Disorders of gut microflora in the pathogenesis of liver cirrhosis and
complications of portal hypertension].
458. Characterizing the metabolic phenotype of intestinal villus blunting in
Zambian children with severe acute malnutrition and persistent diarrhea.
459. Utilization of major fucosylated and sialylated human milk oligosaccharides by
isolated human gut microbes.
460. Prenatal stress affects placental cytokines and neurotrophins, commensal
microbes, and anxiety-like behavior in adult female offspring.
461. Wholegrain oat-based cereals have prebiotic potential and low glycaemic
index.
462. Does Dysbiosis Increase the Risk of Developing Schizophrenia? - A
Comprehensive Narrative Review.
463. Effects of dietary Lactobacillus rhamnosus CF supplementation on growth,
meat quality, and microenvironment in specific pathogen-free chickens.
464. Gut dysbiosis and impairment of immune system homeostasis in perinatally-
exposed mice to Bisphenol A precede obese phenotype development.
465. Bangladesh Environmental Enteric Dysfunction (BEED) study: protocol for a
community-based intervention study to validate non-invasive biomarkers of
environmental enteric dysfunction.
466. Long-term effects of heavy metals and antibiotics on granule-based anammox
process: granule property and performance evolution.
467. Diabetic cognitive dysfunction is associated with increased bile acids in liver
and activation of bile acid signaling in intestine.
468. Isolation and characterization of an agaro-oligosaccharide (AO)-hydrolyzing
bacterium from the gut microflora of Chinese individuals.
469. Symbiotic Human Gut Bacteria with Variable Metabolic Priorities for Host
Mucosal Glycans.
470. Strategies to promote abundance of Akkermansia muciniphila, an emerging
probiotics in the gut, evidence from dietary intervention studies.
471. Environmental enteric dysfunction induces regulatory T cells that inhibit local
CD4+ T cell responses and impair oral vaccine efficacy.
472. In vitro fermentation of B-GOS: impact on faecal bacterial populations and
metabolic activity in autistic and non-autistic children.
473. Mixed conjugated linoleic acid sex-dependently reverses high-fat diet-induced
insulin resistance via the gut-adipose axis.
474. Effects of the Dietary Protein and Carbohydrate Ratio on Gut Microbiomes in
Dogs of Different Body Conditions.
475. The Role of Milk Protein and Whey Permeate in Lipid-based Nutrient
Supplements on the Growth and Development of Stunted Children in
Uganda: A Randomized Trial Protocol (MAGNUS).
476. Vitamin A and Retinoic Acid Exhibit Protective Effects on Necrotizing
Enterocolitis by Regulating Intestinal Flora and Enhancing the
Intestinal Epithelial Barrier.
477. Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to
colonic sensory and motor changes in mice.
478. EFFECT OF CARBOXYLIC ACIDS OF GUT MICROBIAL ORIGIN ON HOST CELL
PROLIFERATION IN ORGANOTYPIC TISSUE CULTURES.
479. Excessive Unbalanced Meat Consumption in the First Year of Life Increases
Asthma Risk in the PASTURE and LUKAS2 Birth Cohorts.
480. Lactobacillus plantarum Strain Ln4 Attenuates Diet-Induced Obesity, Insulin
Resistance, and Changes in Hepatic mRNA Levels Associated with Glucose and
Lipid Metabolism.
481. Copper-induced sublethal effects in Bufo gargarizans tadpoles: growth,
intestinal histology and microbial alternations.
482. Inflammation fuels colicin Ib-dependent competition of Salmonella serovar
Typhimurium and E. coli in enterobacterial blooms.
483. Biotransformation and in vitro metabolic profile of bioactive extracts from a
traditional Miao-nationality herbal medicine, Polygonum capitatum.
484. Effects of intrauterine growth retardation and Bacillus subtilis PB6
supplementation on growth performance, intestinal development and
immune function of piglets during the suckling period.
485. Anti-Allergic Diarrhea Effect of Diosgenin Occurs via Improving Gut Dysbiosis
in a Murine Model of Food Allergy.
486. Impact of feed restriction and housing hygiene conditions on specific and
inflammatory immune response, the cecal bacterial community and the
survival of young rabbits.
487. Dietary Nucleotides Supplementation Improves the Intestinal Development
and Immune Function of Neonates with Intra-Uterine Growth Restriction in a
Pig Model.
488. A Novel Grape-Derived Prebiotic Selectively Enhances Abundance and
Metabolic Activity of Butyrate-Producing Bacteria in Faecal Samples.
489. An agent-based modeling framework for evaluating hypotheses on risks for
developing autism: effects of the gut microbial environment.
490. Protein Malnutrition Modifies Innate Immunity and Gene Expression by
Intestinal Epithelial Cells and Human Rotavirus Infection in Neonatal
Gnotobiotic Pigs.
491. Effects of S24-7 on the weight of progeny rats after exposure to ceftriaxone
sodium during pregnancy.
492. Changes in the intestinal bacterial community, short-chain fatty acid profile,
and intestinal development of preweaned Holstein calves. 1. Effects of
prebiotic supplementation depend on site and age.
493. A gut microbial metabolite of ginsenosides, compound K, induces intestinal
glucose absorption and Na(+) /glucose cotransporter 1 gene expression
through activation of cAMP response element binding protein.
494. Inulin Supplementation Lowered the Metabolic Defects of Prolonged Exposure
to Chlorpyrifos from Gestation to Young Adult Stage in Offspring Rats.
495. Neonatal antibiotic exposure impairs child growth during the first six years of
life by perturbing intestinal microbial colonization.
496. Prevalence and antimicrobial resistance profiles of respiratory microbial flora
in African children with HIV-associated chronic lung disease.
497. Differences in immune status and fecal SCFA between
Indonesian stunted children and children with normal nutritional status.
498. Wheat bran extract alters colonic fermentation and microbial composition, but
does not affect faecal water toxicity: a randomised controlled trial in healthy
subjects.
499. [Antagonistic activity of lactobacilli of the colon].
500. Prevalence of autoantibodies against some selected growth and appetite-
regulating neuropeptides in serum of short children exposed to Candida
albicans colonization and/or Helicobacter pylori infection: the molecular
mimicry phenomenon.
501. Prospecting prebiotics, innovative evaluation methods, and their health
applications: a review.
502. Inhibitory Effect of a Microecological Preparation on Azoxymethane/Dextran
Sodium Sulfate-Induced Inflammatory Colorectal Cancer in Mice.
503. Impact of diet on human gut microbiome and disease risk.
504. Microbial Therapeutics Designed for Infant Health.
505. [Dynamics of contamination and persistence of Clostridium difficile in
intestinal microbiota in newborn infants during antibiotic therapy and use of
probiotic strain enterococcus faecium L3].
506. Potential benefits of colostrum in gastrointestinal diseases.
507. Diversity of bacterial communities on the facial skin of different age-group
Thai males.
508. The influence of nutrition on clinical outcomes in children with cancer.
509. Role of PHGG as a dietary fiber: a review article.
510. Epigenetic Influences on Neurodevelopment at 11 Years of Age: Protocol for
the Longitudinal Peri/Postnatal Epigenetic Twins Study at 11 Years of Age
(PETS@11).
511. Ambient pH regulates secretion of lipases in Malassezia furfur.
512. Effect of a synbiotic on microbial community structure in a continuous culture
model of the gastric microbiota in enteral nutrition patients.
513. Nutrients Mediate Bioavailability and Turnover of Proteins in Mammals.
514. Interplay Between Gut Microbiota and Gastrointestinal Peptides: Potential
Outcomes on the Regulation of Glucose Control.
515. Association between Bioactive Molecules in Breast Milk and Type 1 Diabetes
Mellitus.
516. A simple, semiselective medium for anaerobic isolation of anginosus group
streptococci from patients with chronic lung disease.
517. Transplanting fecal material from wild-type mice fed black raspberries alters
the immune system of recipient mice.
518. Gut microbiome composition is linked to whole grain-induced immunological
improvements.
519. Effect of fucoidan on ethanol-induced liver injury and steatosis in mice and the
underlying mechanism.
520. Diets rich in n-6 PUFA induce intestinal microbial dysbiosis in aged mice.
521. Screening of Probiotic Candidates in Human Oral Bacteria for the Prevention
of Dental Disease.
522. Trimebutine as a potential antimicrobial agent: a preliminary in vitro approach.
523. Sodium butyrate alleviates cholesterol gallstones by regulating bile acid
metabolism.
524. Chili Peppers, Curcumins, and Prebiotics in Gastrointestinal Health and
Disease.
525. Lactobacillus fermentum L930BB and Bifidobacterium animalis subsp. animalis
IM386 initiate signalling pathways involved in intestinal epithelial barrier
protection.
526. Influence of Feeding Omega-3 Polyunsaturated Fatty Acids to Broiler Breeders
on Indices of Immunocompetence, Gastrointestinal, and Skeletal Development
in Broiler Chickens.
527. Bovine milk oligosaccharides decrease gut permeability and improve
inflammation and microbial dysbiosis in diet-induced obese mice.
528. Melatonin Alleviates Neuroinflammation and Metabolic Disorder in DSS-
Induced Depression Rats.
529. Crosstalk between the growth hormone/insulin-like growth factor-1 axis and
the gut microbiome: A new frontier for microbial endocrinology.
530. Clostridium Bacteria and Autism Spectrum Conditions: A Systematic Review
and Hypothetical Contribution of Environmental Glyphosate Levels.
531. Update on FXR Biology: Promising Therapeutic Target?
532. Sex differences in metabolism and cardiometabolic disorders.
533. Probiotic mixture of Lactobacillus helveticus R0052 and Bifidobacterium
longum R0175 attenuates hippocampal apoptosis induced by
lipopolysaccharide in rats.
534. Role of indoleamine 2,3-dioxygenase in pathology of the gastrointestinal tract.
535. Elevation of the vitreous body concentrations of oxidative stress-responsive
apoptosis-inducing protein (ORAIP) in proliferative diabetic retinopathy.
536. Molecular and Lifestyle Factors Modulating Obesity Disease.
537. Mechanisms behind the link between obesity and gastrointestinal cancers.
538. Gut microbial activity, implications for health and disease: the potential role of
metabolite analysis.
539. Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential
Biomarker or New Therapeutic Target.
540. Pathways Connecting Late-Life Depression and Dementia.
541. The Potential Relevance of the Microbiome to Hair Physiology and
Regeneration: The Emerging Role of Metagenomics.
542. A Mathematical Model for the Hydrogenotrophic Metabolism of Sulphate-
Reducing Bacteria.
543. Engineered probiotic and prebiotic nutraceutical supplementations in
combating non-communicable disorders: A review.
544. Nutritional impact on health and performance in intensively reared rabbits.
545. Dietary squid ink polysaccharides ameliorated the intestinal microflora
dysfunction in mice undergoing chemotherapy.
546. Clinical Management of the Microbiome in Irritable Bowel Syndrome.
547. NOD-like receptors in intestinal homeostasis and epithelial tissue repair.
548. Effect of probiotic and prebiotic vs placebo on psychological outcomes in
patients with major depressive disorder: A randomized clinical trial.
549. Long-term safety of early consumption of Lactobacillus fermentum CECT5716:
A 3-year follow-up of a randomized controlled trial.
550. Critical Role of Zinc in a New Murine Model of Enterotoxigenic Escherichia coli
Diarrhea.
551. Role of Helicobacter pylori and Other Environmental Factors in the
Development of Gastric Dysbiosis.
552. The Safety and Efficacy of Microbial Ecosystem Therapeutic-2 in People With
Major Depression: Protocol for a Phase 2, Double-Blind, Placebo-Controlled
Study.
553. Two-Week Aflibercept or Erlotinib Administration Does Not Induce Changes in
Intestinal Morphology in Male Sprague-Dawley Rats But Aflibercept Affects
Serum and Urine Metabolic Profiles.
554. Pathway-based approaches to the treatment of inflammatory bowel disease.
555. Characterization of native Escherichia coli populations from bovine vagina of
healthy heifers and cows with postpartum uterine disease.
556. Development of a Genome-Scale Metabolic Model and Phenome Analysis of
the Probiotic Escherichia coli Strain Nissle 1917.
557. Tissue-resident memory Th17 cells maintain stable fungal commensalism in
the oral mucosa.
558. Unraveling the Complexity of Soil Microbiomes in a Large-Scale Study
Subjected to Different Agricultural Management in Styria.
559. COLOSTRO NONI administration effects on epithelial cells turn-over,
inflammatory events and integrity of intestinal mucosa junctional systems.
560. Bifidobacterium animalis: the missing link for the cancer-preventive effect
of Gynostemma pentaphyllum.
561. Diabetic gastrointestinal motility disorders and the role of enteric nervous
system: current status and future directions.
562. Early-life malnutrition causes gastrointestinal dysmotility that is sexually
dimorphic.
563. The Effect of Administration of a Phytobiotic Containing Cinnamon Oil and
Citric Acid on the Metabolism, Immunity, and Growth Performance of Broiler
Chickens.
564. Converging effects of a Bifidobacterium and Lactobacillus probiotic strain on
mouse intestinal physiology.
565. Campylobacter jejuni increases flagellar expression and adhesion of
noninvasive Escherichia coli: effects on enterocytic Toll-like receptor 4 and
CXCL-8 expression.
566. Functional Bowel Disorders Are Associated with a Central Immune Activation.
567. Biofilm formation, adherence, and hydrophobicity of M. sympodialis, M.
globosa, and M. slooffiae from clinical isolates and normal skinVirulence
factors of M. sympodialis, M. globosa and M. slooffiae.
568. Ozone: a natural bioactive molecule with antioxidant property as potential
new strategy in aging and in neurodegenerative disorders.
569. Neonatal gut and immune maturation is determined more by postnatal age
than by postconceptional age in moderately preterm pigs.
570. Sugarcane molasses enhances TGF-β secretion and FOXP3 gene expression by
Bifidobacterium Animalis Subsp. Lactis stimulated PBMCs of Ulcerative Colitis
patients.
571. Preparation and Optimization of Moxifloxacin Microspheres for Colon
Targeted Delivery Using Quality by Design Approach: In Vitro and In Vivo
Study.
572. The influence of probiotic supplementation on gut permeability in patients
with metabolic syndrome: an open label, randomized pilot study.
573. Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting
Paneth cell production of α-defensins.
574. Obesity-associated mechanisms of hepatocarcinogenesis.
575. Raspberry pomace alters cecal microbial activity and reduces secondary bile
acids in rats fed a high-fat diet.
576. Prostate cancer management: long-term beliefs, epidemic developments in
the early twenty-first century and 3PM dimensional solutions.
577. Eicosapentaenoic and docosahexaenoic acids attenuate hyperglycemia
through the microbiome-gut-organs axis in db/db mice.
578. Immune precision medicine for cancer: a novel insight based on the efficiency
of immune effector cells.
579. Human Milk Oligosaccharides Inhibit Candida albicans Invasion of Human
Premature Intestinal Epithelial Cells.
580. The Brain-Gut-Microbiome Axis.
581. Neovaginoplasty Using Nile Tilapia Fish Skin as a New Biologic Graft in
Patients with Mayer-Rokitansky-Küster-Hauser Syndrome.
582. Therapeutic and Industrial Applications of Curdlan With Overview on Its
Recent Patents.
583. Untargeted Metabolomics Reveals Intestinal Pathogenesis and Self-Repair in
Rabbits Fed an Antibiotic-Free Diet.
584. Lactobacillus rhamnosus CNCM I-3690 and the commensal bacterium
Faecalibacterium prausnitzii A2-165 exhibit similar protective effects to
induced barrier hyper-permeability in mice.
585. Measuring Artificial Sweeteners Toxicity Using a Bioluminescent Bacterial
Panel.
586. Obesity and Liver Cancer.
587. Subversion of Systemic Glucose Metabolism as a Mechanism to Support
the Growth of Leukemia Cells.
588. Urolithin B suppresses tumor growth in hepatocellular carcinoma through
inducing the inactivation of Wnt/beta-catenin signaling.
589. Antimicrobial and Physicochemical Properties of Artificial Saliva Formulations
Supplemented with Core-Shell Magnetic Nanoparticles.
590. Colonic inflammation accompanies an increase of β-catenin signaling and
Lachnospiraceae/Streptococcaceae bacteria in the hind gut of high-fat diet-
fed mice.
591. Evidence of altered mucosa-associated and fecal microbiota composition in
patients with Irritable Bowel Syndrome.
592. Profiles of urine and blood metabolomics in autism spectrum disorders.
593. Dynamic role of single-celled fungi in ruminal microbial ecology and activities.
594. A purified membrane protein from Akkermansia muciniphila or the
pasteurized bacterium improves metabolism in obese and diabetic mice.
595. Bee pollen and propolis improve neuroinflammation and dysbiosis induced by
propionic acid, a short chain fatty acid in a rodent model of autism.
596. RUBIC (ReproUnion Biobank and Infertility Cohort): A binational clinical
foundation to study risk factors, life course, and treatment of infertility and
infertility-related morbidity.
597. Abstracts from the 3rd International Genomic Medicine Conference (3rd IGMC
2015) : Jeddah, Kingdom of Saudi Arabia. 30 November - 3 December 2015.